You don't need to be signed in to read BMJ Blogs, but you can register here to receive updates about other BMJ products and services via our site.

Facioscapulohumeral muscular dystrophy: new insights from compound heterozygotes and implication for prenatal genetic counselling

4 Jan, 12 | by hqqu

Facioscapulohumeral muscular dystrophy (FSHD) is a hereditary muscle disease affecting approximately 1 in 20,000 individuals.  The genetic defect associated with FSHD does not reside in any protein-coding gene.  Instead, FSHD had previously been correlated with a specific set of DNA variations (termed haplotype) at 4q35. Using genetic and clinical information from the Italian National Registry for FSHD, we found that 52% of subjects carrying the disease-associated haplotype are healthy, demonstrating that this haplotype alone is insufficient for disease. In addition, we observed a high number of patients carrying two copies of this haplotype, suggesting a population frequency of 1.2% for this haplotype. Therefore, this set of genetic markers is far more prevalent than FSHD disease, supporting our hypothesis that additional factors are required for disease. Our findings undermine the current paradigms of genetic counseling and prenatal diagnosis for the disease. (By Prof. Rossella Tupler, http://jmg.bmj.com/content/early/2012/01/03/jmedgenet-2011-100454.abstract?papetoc )

By submitting your comment you agree to adhere to these terms and conditions
You can follow any responses to this entry through the RSS 2.0 feed.
JMG blog homepage

JMG Contact

Research developments and evidence-based medical genetics. Visit site

Latest from Journal of Medical Genetics

Latest from Journal of Medical Genetics